Effects of microsomal mono-oxygenase inhibitors upon the in vivo metabolism and duration of action of 1-ethynylcyclohexyl carbamate.
D000480:Alkynes / Q000032:analysis / Q000097:blood / Q000378:metabolism; D000818:Animals; D001921:Brain / Q000378:metabolism; D001923:Brain Chemistry; D002219:Carbamates / Q000032:analysis / Q000097:blood / Q000378:metabolism*; D003510:Cyclohexanes / Q000032:analysis / Q000097:blood / Q000378:metabolism; D004347:Drug Interactions; D005021:Ethylamines / Q000494:pharmacology*; D006207:Half-Life; D008099:Liver / Q000201:enzymology; D008297:Male; D008861:Microsomes / Q000201:enzymology; D010088:Oxidoreductases / Q000378:metabolism; D010634:Phenobarbital / Q000494:pharmacology; D010636:Phenols / Q000494:pharmacology; D011485:Protein Binding / Q000187:drug effects; D051381:Rats; D012890:Sleep / Q000187:drug effects; D013997:Time Factors
D000480:Alkynes; D002219:Carbamates; D003510:Cyclohexanes; D005021:Ethylamines; D010636:Phenols; D010088:Oxidoreductases; D010634:Phenobarbital